Literature DB >> 12971826

Diagnostic criteria of developmental apraxia of speech used by clinical speech-language pathologists.

Karen Forrest1.   

Abstract

The diagnostic criteria used to identify developmental apraxia of speech (DAS) have been at the center of controversy for decades. Despite the difficulty in determining the characteristics that differentiate DAS from other speech acquisition disorders, many children are identified with this disorder. The current report presents the criteria used by 75 speech-language pathologists to establish a diagnosis of DAS. Although 50 different characteristics were identified, 6 of these characteristics accounted for 51.5% of the responses. These characteristics included inconsistent productions, general oral-motor difficulties, groping, inability to imitate sounds, increasing difficulty with increased utterance length, and poor sequencing of sounds. These results are consistent with the general ambiguity of the diagnostic criteria of DAS and suggest that no single deficit is used among clinicians.

Entities:  

Mesh:

Year:  2003        PMID: 12971826     DOI: 10.1044/1058-0360(2003/083)

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  17 in total

1.  12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech.

Authors:  Julien Thevenon; Patrick Callier; Joris Andrieux; Bruno Delobel; Albert David; Sylvie Sukno; Delphine Minot; Laure Mosca Anne; Nathalie Marle; Damien Sanlaville; Marlène Bonnet; Alice Masurel-Paulet; Fabienne Levy; Lorraine Gaunt; Sandra Farrell; Cédric Le Caignec; Annick Toutain; Virginie Carmignac; Francine Mugneret; Jill Clayton-Smith; Christel Thauvin-Robinet; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

2.  An evaluation of articulatory working space area in vowel production of adults with Down syndrome.

Authors:  Kate Bunton; Mark Leddy
Journal:  Clin Linguist Phon       Date:  2010-11-22       Impact factor: 1.346

3.  Changes in movement transitions across a practice period in childhood apraxia of speech.

Authors:  Maria I Grigos; Julie Case
Journal:  Clin Linguist Phon       Date:  2017-12-27       Impact factor: 1.346

Review 4.  Neuroanatomical foundations of naming impairments across different neurologic conditions.

Authors:  Ezequiel Gleichgerrcht; Julius Fridriksson; Leonardo Bonilha
Journal:  Neurology       Date:  2015-06-26       Impact factor: 9.910

5.  Neurophysiology of speech differences in childhood apraxia of speech.

Authors:  Jonathan L Preston; Peter J Molfese; Nina Gumkowski; Andrea Sorcinelli; Vanessa Harwood; Julia R Irwin; Nicole Landi
Journal:  Dev Neuropsychol       Date:  2014       Impact factor: 2.253

6.  Articulatory Control in Childhood Apraxia of Speech in a Novel Word-Learning Task.

Authors:  Julie Case; Maria I Grigos
Journal:  J Speech Lang Hear Res       Date:  2016-12-01       Impact factor: 2.297

7.  An exploratory study of the influence of load and practice on segmental and articulatory variability in children with speech sound disorders.

Authors:  Janet Vuolo; Lisa Goffman
Journal:  Clin Linguist Phon       Date:  2016-12-14       Impact factor: 1.346

8.  The relationship between articulatory control and improved phonemic accuracy in childhood apraxia of speech: a longitudinal case study.

Authors:  Maria I Grigos; Nicole Kolenda
Journal:  Clin Linguist Phon       Date:  2010-01       Impact factor: 1.346

9.  Speech and language support: How physicians can identify and treat speech and language delays in the office setting.

Authors:  Madhavi Moharir; Noel Barnett; Jillian Taras; Martha Cole; E Lee Ford-Jones; Leo Levin
Journal:  Paediatr Child Health       Date:  2014-01       Impact factor: 2.253

Review 10.  Differential Diagnosis of Apraxia of Speech in Children and Adults: A Scoping Review.

Authors:  Kristen M Allison; Claire Cordella; Jenya Iuzzini-Seigel; Jordan R Green
Journal:  J Speech Lang Hear Res       Date:  2020-08-12       Impact factor: 2.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.